Use of an Enzyme-Linked Immunosorbent Assay to Detect Anti-Adherence Protein Antibodies in Sera of Patients with Invasive Amebiasis in Cairo, Egypt

Mohammed D. Abd-AllaEl-Hussein University Hospital, Case Western Reserve University School of Medicine and the Cleveland Veterans Affairs Medical Center, Cairo, Egypt

Search for other papers by Mohammed D. Abd-Alla in
Current site
Google Scholar
PubMed
Close
,
Ahmed M. El-HaweyEl-Hussein University Hospital, Case Western Reserve University School of Medicine and the Cleveland Veterans Affairs Medical Center, Cairo, Egypt

Search for other papers by Ahmed M. El-Hawey in
Current site
Google Scholar
PubMed
Close
, and
Jonathan I. RavdinEl-Hussein University Hospital, Case Western Reserve University School of Medicine and the Cleveland Veterans Affairs Medical Center, Cairo, Egypt

Search for other papers by Jonathan I. Ravdin in
Current site
Google Scholar
PubMed
Close
Restricted access

We used enzyme-linked immunosorbent assay (ELISA) to detect IgG antibodies to the Entamoeba histolytica galactose-inhibitable adherence protein in the sera of 50 uninfected controls, 50 cases with asymptomatic cyst passage, 100 patients with amebic colitis, and six patients with amebic liver abscess from Cairo, Egypt, and in 50 healthy controls from the United States. When the mean + 3 SD value above that of the controls from the United States was used as a criterion for a positive ELISA result, 100% of those with invasive amebiasis, 80% of those with asymptomatic infection, and 64% of the Egyptian controls had anti-adherence protein antibodies. However, when the mean + 2 SD value of Egyptian control sera (optical density = 0.094) was used as the criterion for positivity, 33 (89%) of 37 sera from individuals with invasive amebiasis having symptoms for at least one week were antibody positive, in contrast to only 12% of asymptomatic cyst passers (P < 0.01). In a highly endemic area such as Cairo, Egypt, detection of serum antiadherence protein antibodies by ELISA may have greatest diagnostic use in patients with symptomatic invasive amebiasis of greater than one week duration.

Save